The Latest Breaking News from Novo

A key decision from Eli Lilly could alight the obesity treatment landscape again, an analyst said Friday as LLY stock lingers near a record.

Amgen is years behind rivals in developing an obesity treatment, but the company says its experimental drug could prove superior.

Amgen stock jumped Tuesday on a promising update for its potential rival to obesity treatments from Novo Nordisk and Eli Lilly.

Novo Nordisk A/S’s weekly shot that reduces obesity in adults returned promising results in teens, according to a study that adds to a growing wave of potential interventions for the stubborn condition.

Excitement is building about a new generation of drugs that tout the ability to help adults with excess weight shed more pounds than older drugs on the market.

Amgen stock surged Tuesday on a reportedly bullish call for its experimental obesity treatment — a potential rival to Novo and Lilly.

LOS ANGELES — In September, Steve Lacy sauntered into the glassy upstairs lounge at the Novo in downtown L.A. bearing some remarkable news. The 24-year-old, Compton-raised singer-songwriter, dressed in a flowy trench coat, shoulder-length braids and imposing full-face sunglasses, had just learned that "Bad Habit," his bummed-out yet deliriously horny…

Novo Nordisk said Thursday it will spend $1.1 billion to acquire Forma in a deal that sent biotech stock Forma flying.

A group of pharmaceutical stocks are climbing as they pivot their diabetes drugs to help treat obesity. A potential multibillion-dollar market beckons them.

With a new album to play live, English rock band Royal Blood was ready to go when it launched its tour in the United Kingdom earlier this year.

Novo restaurant in Morpeth has become a big favourite with celebrities including Kieran and his Newcastle United team mates